"10.1371_journal.pone.0142182","plos one","2015-11-11T00:00:00Z","Tudor I Oprea; Larry A Sklar; Jacob O Agola; Yuna Guo; Melina Silberberg; Joshua Roxby; Anna Vestling; Elsa Romero; Zurab Surviladze; Cristina Murray-Krezan; Anna Waller; Oleg Ursu; Laurie G Hudson; Angela Wandinger-Ness","Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America; Translational Informatics Division, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America; Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America; University of New Mexico Center for Molecular Discovery, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America; Division of Epidemiology, Biostatistics, and Preventive Medicine, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America; Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America","Conceived and designed the experiments: TIO LAS JOA YG MS JR AV ZS AWN LGH. Performed the experiments: JOA YG MS JR AV ER ZS. Analyzed the data: TIO LAS JOA YG MS JR AV ZS CMK AW OU AWN LGH. Contributed reagents/materials/analysis tools: TIO LAS AWN LGH. Wrote the paper: TIO LAS JOA YG MS JR AV CMK AW OU AWN LGH. Contributed equally to HTS and cheminformatics: TIO LAS.","Awarded United States Patent and Trademark Office award 9,125,899. September 8, 2015. Title: Modulators of GTPases and Their Use (NSAIDs). Inventors: Angela Wandinger-Ness, Larry A. Sklar, Tudor I. Oprea, Laurie Hudson and Zurab Surviladze. STC (UNMs Science and Technology Transfer office) has offered for license up to 21 technologies including potential pharmaceuticals to ieCrowd, Inc. R-ketorolac is one of the drugs in the portfolio. Larry A. Sklar is a coinventor of HyperCyt and cofounder of IntelliCyt, company that commercializes the platform. The authors hereby confirm that the disclosed competing interests do not alter their adherence to PLOS ONE policies on sharing data and/or materials.","2015","11","Tudor I Oprea","TIO",14,TRUE,10,7,13,12,TRUE,TRUE,FALSE,0,NA,FALSE
